A role for motoneuron subtype-selective ER stress in disease manifestations of FALS mice

Nat Neurosci. 2009 May;12(5):627-36. doi: 10.1038/nn.2297. Epub 2009 Mar 29.

Abstract

The mechanisms underlying disease manifestations in neurodegeneration remain unclear, but their understanding is critical to devising effective therapies. We carry out a longitudinal analysis in vivo of identified motoneurons selectively vulnerable (VUL) or resistant (RES) to motoneuron disease (amyotrophic lateral sclerosis, ALS) and show that subtype-selective endoplasmic reticulum (ER) stress responses influence disease manifestations. VUL motoneurons were selectively prone to ER stress and showed gradually upregulated ER stress markers from birth on in three mouse models of familial ALS (FALS). 25-30 days before the earliest denervations, ubiquitin signals increased in both VUL and RES motoneurons, but an unfolded protein response coupled with microglial activation was initiated selectively in VUL motoneurons. This transition was followed by selective axonal degeneration and spreading stress. The ER stress-protective agent salubrinal attenuated disease manifestations and delayed progression, whereas chronic enhancement of ER stress promoted disease. Thus, whereas all motoneurons are preferentially affected in ALS, ER stress responses in specific motoneuron subtypes influence the progressive manifestations of weakening and paralysis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amyotrophic Lateral Sclerosis / genetics*
  • Amyotrophic Lateral Sclerosis / metabolism*
  • Amyotrophic Lateral Sclerosis / physiopathology
  • Animals
  • Biomarkers / analysis
  • Biomarkers / metabolism
  • Central Nervous System / metabolism*
  • Central Nervous System / pathology
  • Central Nervous System / physiopathology
  • Cinnamates / pharmacology
  • Disease Models, Animal
  • Disease Progression
  • Endoplasmic Reticulum / genetics
  • Endoplasmic Reticulum / metabolism*
  • Genetic Predisposition to Disease / genetics
  • Gliosis / genetics
  • Gliosis / metabolism
  • Gliosis / physiopathology
  • Mice
  • Mice, Neurologic Mutants
  • Microglia / metabolism
  • Motor Neurons / classification
  • Motor Neurons / metabolism*
  • Motor Neurons / pathology
  • Neuroprotective Agents / pharmacology
  • Oxidative Stress / genetics*
  • Phenotype
  • Protein Folding
  • Thiourea / analogs & derivatives
  • Thiourea / pharmacology
  • Ubiquitin / metabolism
  • Ubiquitination
  • Wallerian Degeneration / genetics
  • Wallerian Degeneration / metabolism
  • Wallerian Degeneration / physiopathology

Substances

  • Biomarkers
  • Cinnamates
  • Neuroprotective Agents
  • Ubiquitin
  • salubrinal
  • Thiourea